Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Christopher Bunka$28.2M
Market Cap • 25/04/20242004
(há 20 anos)
2006
(18 years ago)
NASDAQ
Listagem
Kelowna
Sede • BC6
N° de Empregados • 2021Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
LEXXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.